Who
Daniel J. Becker
Director
Company insider
Files Form 4 as: Director, Zura Bio; Director, Acelyrin; Director, Day One Biopharmaceuticals; Director and 10% owner, Pandion Therapeutics; Director and 10% owner, Principia Biopharma.
In numbers
- Trades disclosed
- 50
- Buys
- 11
- Sells
- 1
- Bought
- $40.4M
- Sold
- $7
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 13 Sep 2018
- Last trade
- 17 Jun 2026
- Last filed
- 22 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 17 Jun 2026filed 22 Jun 2026 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —51,000 at $0.00 | filing |
| 17 Jun 2026filed 22 Jun 2026 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —51,000 at $0.00 | filing |
| 29 May 2025filed 29 May 2025 | ZURA Zura Biooption or derivative · Biotechnology | SEC FORM 4 Code A | —51,000 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | Acelyrinoption or derivative | SEC FORM 4 Code D | —23,243 | filing |
| 21 May 2025filed 23 May 2025 | Acelyrinoption or derivative | SEC FORM 4 Code D | —92,158 | filing |
| 21 May 2025filed 23 May 2025 | Acelyrin | SEC FORM 4 Code D | —2,999 | filing |
| 17 Jul 2024filed 19 Jul 2024 | Acelyrin | SEC FORM 4 Sold | $71 at $6.86 | filing |
| 7 Jun 2024filed 11 Jun 2024 | Acelyrinoption or derivative | SEC FORM 4 Code A | —92,158 at $0.00 | filing |
| 22 Jun 2023filed 26 Jun 2023 | Day One Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —37,500 at $0.00 | filing |
| 9 May 2023filed 11 May 2023 | Acelyrinoption or derivative | SEC FORM 4 Code J | —23,243 at $0.00 | filing |
| 9 May 2023filed 11 May 2023 | Acelyrinoption or derivative | SEC FORM 4 Code J | —23,243 at $0.00 | filing |
| 9 May 2023filed 11 May 2023 | Acelyrin | SEC FORM 4 Bought | $54K3,000 at $18.00 | filing |
| 4 May 2023filed 4 May 2023 | Acelyrinoption or derivative | SEC FORM 4 Code A | —23,243 at $0.00 | filing |
| 21 Jun 2022filed 23 Jun 2022 | Day One Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —28,700 at $0.00 | filing |
| 1 Jun 2021filed 1 Jun 2021 | Day One Biopharmaceuticals | SEC FORM 4 Bought | $80K5,000 at $16.00 | filing |
| 26 May 2021filed 1 Jun 2021 | Day One Biopharmaceuticalsoption or derivative | SEC FORM 4 Code A | —63,000 at $0.00 | filing |
| 1 Apr 2021filed 1 Apr 2021 | Pandion Therapeutics | SEC FORM 4 Code U | $60K1,000 at $60.00 | filing |
| 1 Apr 2021filed 1 Apr 2021 | Pandion Therapeutics | SEC FORM 4 Code U | $169.7M2,827,883 at $60.00 | filing |
| 1 Apr 2021filed 1 Apr 2021 | Pandion Therapeuticsoption or derivative | SEC FORM 4 Code D | —13,997 | filing |
| 19 Nov 2020filed 23 Nov 2020 | Pandion Therapeutics | SEC FORM 4 Bought | $3.0M197,716 at $15.12 | filing |
News
No headline names them, or the companies they trade most, lately.